Proteocyte Diagnostics
PrivateLast Round
Seed
Sep 10, 2014
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Proteocyte Diagnostics is a biotechnology company that develops and commercializes molecular diagnostics tests, including its flagship oral cancer risk prediction test, Straticyte.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Proteocyte Diagnostics Comparables
Compare Proteocyte Diagnostics with similar companies based on industry and business-model similarity.
No public comparables are available for Proteocyte Diagnostics. Request access to learn about comparables coverage.
Request accessProteocyte Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 10, 2014 |
Proteocyte Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wilfrid Laurier University | Seed |
| MaRS Discovery District | Seed |
| Freycinet Ventures | Seed |
| Golden Triangle Angel Network | Seed |
| Ontario Centre of Innovation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Web traffic grew 44% MoM (from 7.6K to 10.9K monthly visitors)
- May 17, 2026
Web traffic grew 177% MoM (from 2.7K to 7.6K monthly visitors)
Proteocyte Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Proteocyte Diagnostics's valuation, stock price, and market status.
Is Proteocyte Diagnostics a public or private company?
Proteocyte Diagnostics is a private company.
What is the current stock price of Proteocyte Diagnostics?
Proteocyte Diagnostics is a private company with no public stock price. Caplight tracks Proteocyte Diagnostics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Proteocyte Diagnostics worth (valuation)?
Valuation information for Proteocyte Diagnostics is not publicly available.
Can I buy Proteocyte Diagnostics stock?
Proteocyte Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Proteocyte Diagnostics's last funding round?
Proteocyte Diagnostics's most recent funding round was Seed on September 10, 2014.
Who are the main investors in Proteocyte Diagnostics?
Key investors in Proteocyte Diagnostics include Wilfrid Laurier University, MaRS Discovery District, Freycinet Ventures, Golden Triangle Angel Network, Ontario Centre of Innovation.
Will Proteocyte Diagnostics IPO soon?
No public IPO plans have been announced for Proteocyte Diagnostics.
How can I track Proteocyte Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Proteocyte Diagnostics's secondary market activity and sign up for updates.